FFS Pharma
I'm not talking about the great but snail pace way to fund anything other than the CEO's salary.
I'm talking about why, after 20 years of
MK research, 7 years of MOU's, an ever growing pending list, symposium pow wows, etc. ..has the CEO failed to attract a significant investor that believes in MK enough to fast forward the above?
Ann: USA launch of evolis-CDY.AX, page-65
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 565639 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 80000 | 1 |
View Market Depth
| Last trade - 16.12pm 03/09/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable